DCM
DFTX

Driehaus Capital Management’s Definium Therapeutics DFTX Stock Holding History

Driehaus Capital Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$112M Sell
5,911,889
-625,313
-10% -$10.6M 0.82% 21
2025
Q4 		$87.5M Buy
6,537,202
+3,427,291
+110% +$42.4M 0.59% 43
2025
Q3 		$36.7M Buy
3,109,911
+17,253
+0.6% +$161K 0.26% 128
2025
Q2 		$20.1M Sell
3,092,658
-258,747
-8% -$1.7M 0.16% 176
2025
Q1 		$19.6M Sell
3,351,405
-24,802
-0.7% -$178K 0.19% 164
2024
Q4 		$23.5M Sell
3,376,207
-517,920
-13% -$3.56M 0.19% 158
2024
Q3 		$22.2M Buy
3,894,127
+1,355,717
+53% +$9.43M 0.19% 158
2024
Q2 		$18.3M Sell
2,538,410
-9,135
-0.4% -$79.9K 0.18% 162
2024
Q1 		$23.9M Buy
+2,547,545
New +$14.5M 0.24% 123

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM

Driehaus Capital Management's DFTX Position: Q1 2026 in Review

Driehaus Capital Management reduced its Definium Therapeutics (DFTX) stake by 9.6% in Q1 2026, selling an estimated $10.6M and leaving 5,911,889 shares worth $112M. The position accounts for 0.82% of the portfolio, ranked #21.

Driehaus Capital Management first reported a position in DFTX in Q1 2024 and has held it in 9 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Driehaus Capital Management held 5,911,889 shares of Definium Therapeutics worth $112M as of Q1 2026.
  • Driehaus Capital Management sold 625,313 Definium Therapeutics shares in Q1 2026, an estimated $10.6M.
  • Definium Therapeutics made up 0.82% of Driehaus Capital Management's portfolio in Q1 2026, its #21 holding.
  • Driehaus Capital Management first reported a position in Definium Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.